Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fonck

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2015
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et alT de Baère, A Aupérin, F Deschamps, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2015
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastasesT de Baère, A Aupérin, F Deschamps, et al.
Psycho-Oncology|February 26, 2016
Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapyS Duc, M Rainfray, P Soubeyran, et al.
The British Journal of Surgery|March 8, 2012
Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resectionS Evrard, M Rivoire, J -P Arnaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)C Louvet, T André, P Hammel, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
British Journal of Cancer|September 18, 2008
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patientsE Rouits, V Charasson, A Pétain, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2015
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et alT de Baère, A Aupérin, F Deschamps, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2015
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastasesT de Baère, A Aupérin, F Deschamps, et al.
Psycho-Oncology|February 26, 2016
Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapyS Duc, M Rainfray, P Soubeyran, et al.
The British Journal of Surgery|March 8, 2012
Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resectionS Evrard, M Rivoire, J -P Arnaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)C Louvet, T André, P Hammel, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
British Journal of Cancer|September 18, 2008
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patientsE Rouits, V Charasson, A Pétain, et al.
Pageof 2